SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-05-010817
Filing Date
2005-04-07
Accepted
2005-04-07 16:45:55
Documents
2
Period of Report
2005-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v15973_8k.htm 8-K 33045
2 v15973_ex99-1.htm EX-99.1 29138
  Complete submission text file 0001144204-05-010817.txt   64371
Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 2125544555
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27282 | Film No.: 05739591
SIC: 2834 Pharmaceutical Preparations